Acromelic Frontonasal Dysostosis (AFND)

Acromelic frontonasal dysostosis (AFND) is a very rare genetic condition. It affects the face (especially the middle of the face and nose), the brain in some children, and the limbs—most often the legs and feet. Doctors first notice wide-set eyes, a split or very broad nasal tip, and a midline facial cleft. Many children also have limb changes such as missing or under-developed shin bones (tibia), clubfoot, and extra toes on the inner side of the feet (preaxial polydactyly). AFND is caused by a change (variant) in a gene called ZSWIM6. The variant is usually new in the child (de novo) and follows an autosomal-dominant pattern when inherited. Research suggests this gene change can disturb the Hedgehog signaling pathway, which guides early face, brain, and limb development. In short: the condition begins before birth, comes from a single gene change, and care focuses on supportive therapies and surgery to improve function and appearance. PMC+1Naturesearch.clinicalgenome.orgMalaCards

Acromelic frontonasal dysostosis is a very rare genetic condition that affects how the face, brain, and limbs form before birth. Children usually have a frontonasal malformation (wide-set eyes and a split or “bifid” nose with a midline facial cleft), brain changes such as problems with the corpus callosum or an interhemispheric lipoma, and limb changes such as extra toes on the big-toe side (preaxial polydactyly), tibial under-development, and clubfoot. The condition has been reported only in a small number of people worldwide. PubMedPMCMalaCards

Another names

• Acromelic frontonasal dysplasia (same condition; “dysplasia” is used in some medical sources). Orpha.net

• Toriello syndrome (historical name used when this pattern was first grouped as a subtype of frontonasal dysplasia). PMC

• Frontonasal dysplasia with limb anomalies or frontonasal malformation with preaxial polydactyly and tibial defects (descriptive phrases used in reports). PMC

---

Types

Because this disorder is so rare, doctors talk about phenotypic spectrum rather than official subtypes. Thinking in “types” can still help:

1. Classic AFND – Severe, symmetric frontonasal clefting with widely separated nostrils, plus lower-limb changes (preaxial polydactyly, tibial hypoplasia/aplasia, and clubfoot). Brain findings such as callosal agenesis or interhemispheric lipoma are common. PMC

2. AFND with normal limbs – The same distinctive frontonasal changes and brain findings but without limb anomalies (documented in rare cases). PMC

3. Mosaic/attenuated AFND – A milder appearance in a parent (for example, hypertelorism and a bifid nasal tip) caused by mosaicism for the causal variant; the child can be severely affected. PMC

---

Causes

Important note: AFND is a monogenic disorder. The single, well-supported genetic cause is a specific change in one gene. The “20 causes” below explain that core cause, the contexts in which it appears, and the biological mechanisms through which it leads to the features of AFND.

1. Pathogenic change in the ZSWIM6 gene – A heterozygous missense change at c.3487C>T (p.Arg1163Trp) is found again and again in AFND and is considered the defining cause. PubMed

2. De novo origin – In most families the variant appears new in the affected child (not present in either parent’s blood). PubMed

3. Autosomal-dominant effect – One altered copy is enough to cause the condition. ClinGen classifies the ZSWIM6–AFND gene-disease link as definitive with autosomal-dominant inheritance. search.clinicalgenome.org

4. Parental mosaicism – A parent can carry the variant in a small percentage of cells (not always detectable in blood) and show only mild facial signs; this raises recurrence risk for future pregnancies. PMC

5. Disruption of a conserved protein region – The p.Arg1163Trp change alters a highly conserved Sin3-like domain at the protein’s tail (C-terminus), likely damaging its function. PubMed

6. Hedgehog signaling disturbance – Studies of patient cells suggest abnormal Hedgehog pathway activity, a key pathway for face, brain, and limb patterning. PubMed

7. Neural crest patterning errors – By disturbing early patterning signals, the variant likely affects neural crest cells that form midline facial structures (a mechanistic bridge to the bifid nose and midline cleft). (Inference from Hedgehog role in craniofacial development supported by source 6.)

8. Forebrain midline development changes – The same pathway changes may interrupt corpus callosum formation, explaining agenesis/dysgenesis and associated interhemispheric lipoma seen on MRI. PubMed

9. Limb bud anterior–posterior patterning – Hedgehog pathway imbalance can shift the preaxial/postaxial identity in the limb bud, explaining preaxial polydactyly and tibial hypoplasia/aplasia. PMC

10. Variable expressivity – The same variant can cause severe multi-system involvement in one person and mild facial signs in another, especially with mosaicism. PMC

11. Tissue-specific expression of ZSWIM6 – ZSWIM6 is expressed in multiple embryonic tissues, with higher expression in the brain; damaging it has multi-organ effects. PMC

12. Ubiquitous but dosage-sensitive function – Even though the gene is widely expressed, certain tissues (face, brain, limbs) are more sensitive to small changes in ZSWIM6 function. (Inference supported by expression and phenotype in sources 1 and 2.)

13. Developmental timing – The variant acts during early embryonic windows when midline face and limb structures are specified; timing amplifies impact. (Mechanistic inference consistent with sources 1–2.)

14. Germline heterozygosity vs. mosaic heterozygosity – Germline heterozygosity tends to produce classic AFND, while low-level mosaic heterozygosity can produce milder or atypical features. PMC

15. Deep sequencing detection limits – Routine Sanger testing can miss low-level mosaicism; more sensitive next-generation sequencing of multiple tissues can uncover it, explaining “negative” parental tests. PMC

16. Sporadic prevalence – The rarity of the condition (fewer than ~20 well-documented cases in early literature) reflects how rarely this exact single-nucleotide change occurs. PMC

17. No proven environmental cause – To date, no maternal illness, medication, or exposure has been shown to cause AFND; the driver is genetic. (Negative statement based on the genetic literature above.)

18. Not due to chromosomal aneuploidy – AFND is not a chromosome-number disorder; chromosomal microarray is typically normal because the cause is a single-gene point variant. PubMed

19. Pathway cross-talk – ZSWIM6 disruption may indirectly alter other patterning pathways that co-operate with Hedgehog during craniofacial and limb development, magnifying effects. (Mechanistic inference aligned with source 6.)

20. Animal and cellular data support causality – Expression studies in zebrafish and mouse embryos, plus functional readouts in patient cells, support ZSWIM6’s role in early development and validate the variant as causal, not incidental. PubMed

---

Symptoms and clinical features

1. Wide-set eyes (hypertelorism) – Distance between the eyes is larger than normal; this is one of the most consistent signs. PMC

2. Bifid or clefted nose – The nose is split in the midline with widely separated nostril openings. PMC

3. Midline facial cleft – A true median cleft can involve the upper lip and maxilla; some children have a carp-shaped mouth or cleft palate. PubMed

4. Anterior cranium bifidum / large fontanelle / parietal foramina – Gaps in the skull bones along the midline reflect midline development differences. PubMed

5. Interhemispheric lipoma – A fatty mass along the brain midline on MRI, often with partial or complete agenesis of the corpus callosum. PubMed

6. Global developmental delay – Many children have delayed motor and language milestones; some do not develop speech or independent walking. PMC

7. Intellectual disability – Learning difficulties are common and can be severe. MalaCards

8. Preaxial polydactyly of the feet – Extra toe(s) on the big-toe side; hands are usually normal. PMC

9. Tibial hypoplasia/aplasia (tibial hemimelia) – The shin bone is under-developed or absent, leading to limb length and alignment issues. PMC

10. Clubfoot (talipes equinovarus) – The feet turn inward and downward; often needs orthopedic care. PMC

11. Ptosis or eyelid differences – Droopy eyelids have been reported in some children. PMC

12. Cataracts (occasionally) – Clouding of the lens has been noted in at least one reported child. PMC

13. Genitourinary differences (in some boys) – Findings such as cryptorchidism and micropenis have been described. PMC

14. Spinal curvature (scoliosis) in some cases – Postnatal musculoskeletal follow-up may be needed. PMC

15. Normal limb appearance in rare cases – A small number of individuals show the facial/brain pattern without limb anomalies. PMC

(Severity varies widely, even within the same family when mosaicism is present.) PMC

---

Diagnostic tests

A) Physical examination

1. Detailed craniofacial exam – The clinician measures eye spacing, nasal contour, and midline structures, looking for the hallmark pattern (hypertelorism, bifid nose, midline cleft). These visual signs guide targeted genetic testing. PMC

2. Oral and palate inspection – Checking for a carp-shaped mouth, lip notch, or cleft palate helps document the full extent of the midline clefting. PubMed

3. Neurologic screening – Tone, reflexes, and developmental milestones are assessed because AFND often coexists with brain malformations and global delay. PMC

4. Musculoskeletal/limb exam – The feet and legs are examined for preaxial polydactyly, tibial under-development, and clubfoot, which influence orthopedic planning. PMC

5. Ophthalmic exam at bedside – Basic vision checks and eyelid assessment (for ptosis) are part of the first look, with referral to pediatric ophthalmology as needed. PMC

B) Manual/bedside tests

6. Anthropometric measurements – Head circumference, inter-canthal distance, and nasal width are measured and plotted to objectively document hypertelorism and craniofacial proportions. PMC

7. Feeding and airway evaluation – Simple bedside assessments can detect feeding difficulty or nasal airflow issues related to the midline cleft and bifid nose, guiding early support. (Clinical best practice aligned with craniofacial malformation care.)

8. Hearing screen – Newborn/child hearing checks (otoacoustic emissions/auditory brainstem screen) are advisable because clefts and craniofacial differences can affect Eustachian tube function. (Standard cleft-care practice.)

9. Orthopedic functional checks – Range-of-motion and weight-bearing assessments gauge how tibial deficiency and clubfoot affect mobility and help time bracing or surgery. PMC

10. Ophthalmology slit-lamp exam – A manual instrument exam can detect cataracts or other anterior-segment issues reported in some cases. PMC

C) Laboratory and pathological tests

11. Single-gene sequencing of ZSWIM6 – Targeted sequencing looks for the c.3487C>T (p.Arg1163Trp) variant; a positive result confirms the molecular diagnosis in the right clinical context. PubMed

12. Exome or genome sequencing – If targeted testing is negative or the presentation is atypical, exome/genome testing can detect the same ZSWIM6 variant or other craniofacial genes; exome identified the recurrent AFND variant in original studies. PubMed

13. Parental testing for mosaicism – When a child is positive, parents may undergo deep sequencing of multiple tissues (blood, buccal cells, urine, etc.) to look for low-level mosaicism, which standard tests can miss. PMC

14. Chromosomal microarray (CMA) – Usually normal in AFND, but useful to rule out large deletions/duplications and to complete a comprehensive genetic evaluation. PubMed

15. Functional assays (research settings) – In some reports, patient fibroblasts showed Hedgehog pathway activation on qRT-PCR; this is not a routine clinical test but supports mechanism. PubMed

16. Standard pediatric labs as needed – Routine labs (CBC, electrolytes) are not diagnostic for AFND but help prepare for anesthesia, surgery, or manage associated conditions. (General clinical practice.)

D) Electrodiagnostic tests

17. EEG (if seizures or spells are suspected) – Brain malformations may raise seizure risk; EEG documents abnormal electrical activity and guides anti-seizure care when needed. (General neurology practice for midline brain anomalies.)

18. Auditory brainstem response (ABR) – Objective electrodiagnostic hearing test, especially useful if behavioral hearing testing is unreliable due to developmental delay. (Standard pediatric audiology practice.)

E) Imaging tests

19. Brain MRI – Looks for interhemispheric lipoma, agenesis/dysgenesis of the corpus callosum, and other midline brain malformations; this is a cornerstone study in AFND. PubMed

20. Craniofacial CT (low-dose protocols when possible) – Defines bony anatomy such as anterior cranium bifidum, true midline maxillary cleft, and parietal foramina; important for surgical planning. PubMed

21. Skeletal radiographs of the lower limbs – Document tibial hypoplasia/aplasia, alignment, and the pattern of preaxial polydactyly to guide orthopedics. PMC

22. Foot/ankle radiographs – Detail the clubfoot bones and joints and help plan casting or surgical correction. PMC

23. Prenatal ultrasound – May detect orbital hypertelorism, nasal hypoplasia or bifidity, and clubfoot during the second trimester; these findings can prompt genetic counseling and planning. PMC

24. Fetal MRI (when available) – Clarifies brain midline structures and can detect an interhemispheric lipoma or callosal agenesis before birth. PubMed

25. Post-operative imaging as needed – After craniofacial or orthopedic surgery, imaging ensures bones and joints are healing and aligned (clinical practice standard).

Non-pharmacological treatments

Below are practical, evidence-informed options. They do not replace specialist care. They support comfort, function, growth, learning, and post-operative recovery.

A) Physiotherapy & rehabilitation interventions

(Each item includes: description ~100 words, purpose, mechanism, benefits.)

1. Early developmental physiotherapy
   Description: A gentle, play-based program started in infancy. The therapist coaches caregivers on tummy time, rolling, sitting balance, reaching, and safe transitions. If legs or feet have structural differences, sessions add positioning aids, supported standing, and weight-bearing practice with braces or splints as advised by orthopedics. Therapy is adapted to any brain findings (for example, low tone or coordination issues). Home programs are short and frequent.
   Purpose: Promote motor milestones and prevent secondary stiffness.
   Mechanism: Repeated task practice builds neural pathways and joint range.
   Benefits: Better head–trunk control, earlier sitting/standing, easier caregiving.

2. Gait training with assistive devices
   Description: Once weight-bearing is safe, the therapist uses parallel bars, walkers, or crutches. For clubfoot or tibial hypoplasia, they trial orthoses (AFOs/KAFOs) and shoe inserts to improve alignment and foot clearance. Sessions focus on step symmetry, speed, turning, and safe obstacle negotiation. Progress is measured with timed tests and video.
   Purpose: Enable safe, efficient walking.
   Mechanism: External support + task repetition retrain balance and limb loading.
   Benefits: Reduced falls, more independence, less energy cost during walking.

3. Strengthening of proximal (core/hip) muscles
   Description: Simple, child-friendly drills (bridges, sit-to-stand, step-ups) with elastic bands or body weight. For limb differences, the program emphasizes the muscles that stabilize the pelvis and trunk so the legs can move more safely.
   Purpose: Build the “engine” that supports legs and posture.
   Mechanism: Muscle overload and recovery increase fiber strength and endurance.
   Benefits: Better gait, less compensatory sway, lower fatigue.

4. Range-of-motion and contracture prevention
   Description: Daily gentle stretches for ankles, knees, and hips; serial casting if clubfoot is present and the orthopedic team recommends it. Parents learn safe hold times and how to watch for pain or skin marks.
   Purpose: Keep joints flexible while bones and soft tissues grow.
   Mechanism: Low-load, long-duration stretch remodels connective tissue.
   Benefits: Easier bracing, better shoe fit, safer standing.

5. Balance and coordination training
   Description: Age-appropriate games: single-leg stance with support, stepping stones, foam surfaces, catching/throwing, and obstacle courses. Intensity increases slowly.
   Purpose: Reduce falls and improve confidence.
   Mechanism: Challenges the vestibular and proprioceptive systems to adapt.
   Benefits: Steadier gait, readiness for play and school activities.

6. Pain-modulating modalities (non-drug)
   Description: Heat packs for tight muscles, cold packs for post-exercise soreness, gentle massage, and TENS (if advised by the clinician) for short-term relief.
   Purpose: Lower pain to permit exercise and daily activities.
   Mechanism: Gate control and local circulation changes reduce pain signals.
   Benefits: Better tolerance of therapy and braces; improved sleep.

7. Post-operative physiotherapy pathway
   Description: After craniofacial or limb surgery, the team provides breathing exercises, safe mobility, edema control (elevation/compression), and a graded return-to-activity plan tied to bone and soft-tissue healing timelines.
   Purpose: Protect the repair while preventing deconditioning.
   Mechanism: Early, gentle activation preserves muscle and joint function.
   Benefits: Faster functional recovery, fewer complications. PubMed

8. Orthotic management and splinting
   Description: Custom ankle-foot orthoses, knee–ankle–foot orthoses, shoe raises, and night splints as needed. Orthotists adjust devices as the child grows.
   Purpose: Improve alignment and distribute pressure.
   Mechanism: External control guides joints into safer mechanical positions.
   Benefits: More stable standing/walking; reduced pain and skin breakdown.

9. Wheelchair and mobility skills (when appropriate)
   Description: If walking is limited, clinicians teach safe transfers, wheelchair propulsion, and community mobility (ramps, curbs, transport).
   Purpose: Ensure participation and safety.
   Mechanism: Skills training + fit optimization.
   Benefits: Independence at home and school; reduced caregiver strain.

10. Respiratory and airway care coaching
    Description: For children with nasal or midface structural issues, therapists and nurses teach nasal saline care, humidification, and positioning for sleep. They also practice bubble-PEP or incentive breathing if advised after surgery.
    Purpose: Keep airways clear and comfortable.
    Mechanism: Humidification and gentle pressure improve mucociliary flow.
    Benefits: Easier breathing, fewer irritation symptoms. rchsd.org

11. Scar management education
    Description: Once wounds are closed and the surgeon approves, families learn silicone gel/sheets use, gentle scar massage, sun protection, and how to spot hypertrophic changes.
    Purpose: Support soft, flexible, less-noticeable scars.
    Mechanism: Hydration and mechanical input modulate collagen remodeling.
    Benefits: Better cosmetic result; less itch/tightness.

12. Functional hand and fine-motor training
    Description: If there are hand/thumb differences, occupational therapists guide grasp patterns, in-hand manipulation, buttoning/zipping practice, adapted pencil grips, and utensil training.
    Purpose: Improve daily living and school tasks.
    Mechanism: Task-specific repetition strengthens neuromotor control.
    Benefits: Greater independence with dressing, writing, eating.

13. Feeding and oral-motor therapy
    Description: For infants with midline facial clefts or weak lip seal, speech/feeding therapists teach paced feeding, special nipples, and oral-motor stimulation. Older children practice chewing variety and safe swallowing post-surgery.
    Purpose: Safe nutrition and growth.
    Mechanism: Gradual strengthening of orofacial muscles and coordination.
    Benefits: Fewer spills/choking, better weight gain.

14. Speech and resonance therapy
    Description: If nasal airflow affects speech sounds, therapists work on breath support, articulation placement, and resonance strategies. They coordinate with surgeons if velopharyngeal insufficiency is suspected.
    Purpose: Improve intelligibility and confidence.
    Mechanism: Motor learning with feedback and home practice.
    Benefits: Clearer speech; better school participation.

15. Education for safe play and PE
    Description: Physiotherapists write simple school activity plans: which sports are safe, what supports are needed, and how to modify tasks after surgery.
    Purpose: Inclusion without injury.
    Mechanism: Risk management + graded exposure.
    Benefits: Social participation; healthy habits.

B) Mind-body, “gene,” and educational therapies

16. Family-centered counseling
    Description: Brief, strengths-based sessions help families understand the condition, set goals, and manage stress around surgeries and therapies.
    Purpose: Lower emotional burden; improve adherence.
    Mechanism: Psychoeducation and coping skills.
    Benefits: Better communication and follow-through.

17. Cognitive-behavioral pain and anxiety skills
    Description: Simple tools like paced breathing, guided imagery, and thought-feeling mapping before procedures and casts.
    Purpose: Reduce fear and pain perception.
    Mechanism: Top-down modulation of threat and arousal.
    Benefits: Calmer procedures; fewer meltdowns.

18. Genetic counseling (not “gene therapy”)
    Description: A genetics professional explains ZSWIM6, recurrence risks, and options for prenatal testing in future pregnancies.
    Purpose: Informed family planning.
    Mechanism: Risk assessment and education.
    Benefits: Clear expectations; less uncertainty. search.clinicalgenome.org

19. School-based individualized education plan (IEP)
    Description: The team documents learning, speech, and mobility needs, plus accommodations after operations.
    Purpose: Access to education.
    Mechanism: Legal plan with measurable goals.
    Benefits: Better attendance and performance.

20. Social skills and self-esteem groups
    Description: Age-matched peer groups that normalize differences and practice communication.
    Purpose: Build resilience.
    Mechanism: Supported exposure and positive feedback.
    Benefits: Lower bullying impact; stronger self-image.

21. Care coordination (“medical home”)
    Description: A central clinician or nurse coordinates appointments among craniofacial, orthopedic, rehab, and school services.
    Purpose: Reduce missed care and repetition.
    Mechanism: Shared plan and calendar.
    Benefits: Smoother journey for the family.

22. Pre-surgical preparation program
    Description: Child-friendly tours, videos, and play-acting with masks and monitors.
    Purpose: Reduce peri-operative anxiety.
    Mechanism: Familiarization lowers threat response.
    Benefits: Easier anesthesia induction; smoother recovery.

23. Nutritional coaching
    Description: A dietitian aligns calories and protein with growth and healing; suggests textures if chewing is hard; and prevents constipation after surgery.
    Purpose: Support growth and wound healing.
    Mechanism: Adequate macro/micronutrients.
    Benefits: Better weight trends; fewer GI issues.

24. Future-facing “gene-based” education (research only)
    Description: Families learn how scientists study AFND—cell models, animal models, and pathway biology (Hedgehog). No approved gene therapy exists for AFND.
    Purpose: Realistic expectations and trial awareness.
    Mechanism: Knowledge of current science.
    Benefits: Informed consent if research opportunities arise. PMC

25. Community support and advocacy linkage
    Description: Connecting with rare-disease groups and craniofacial networks for practical tips and psychosocial support.
    Purpose: Reduce isolation; share resources.
    Mechanism: Peer mentorship.
    Benefits: Coping and problem-solving improve.

---

Drug treatments

Important safety note: Doses in children depend on weight, age, kidney/liver function, and surgical plan. Always follow your specialist’s exact prescription.

1. Paracetamol (Acetaminophen)
   Class: Analgesic/antipyretic.
   Dose/Time: 10–15 mg/kg per dose every 6 hours (max 60 mg/kg/day in many pediatric protocols).
   Purpose: Pain/fever control after procedures or therapy days.
   Mechanism: Central COX inhibition and serotonergic pathways.
   Side effects: Rare liver toxicity at high doses or with overdose.

2. Ibuprofen
   Class: NSAID.
   Dose/Time: ~10 mg/kg every 6–8 hours (avoid <6 months unless directed).
   Purpose: Post-op or musculoskeletal pain and inflammation.
   Mechanism: COX-1/COX-2 inhibition.
   Side effects: Stomach upset, kidney strain, bleeding risk—avoid around some surgeries if surgeon advises.

3. Morphine (hospital use)
   Class: Opioid analgesic.
   Dose/Time: Common IV starting range 0.05–0.1 mg/kg every 2–4 hours as needed (inpatient protocols vary).
   Purpose: Immediate post-operative pain.
   Mechanism: μ-opioid receptor agonism.
   Side effects: Sedation, nausea, constipation, respiratory depression—monitoring required.

4. Levetiracetam
   Class: Antiseizure medicine.
   Dose/Time: Often 10 mg/kg twice daily up-titrated (specialist sets dose).
   Purpose: Seizures if brain malformations are present.
   Mechanism: Modulates synaptic vesicle protein SV2A.
   Side effects: Irritability, sleep changes; rare behavior effects.

5. Cefazolin (peri-operative prophylaxis)
   Class: First-generation cephalosporin (IV).
   Dose/Time: Weight-based IV just before incision per surgical protocol.
   Purpose: Reduce surgical site infection risk.
   Mechanism: Inhibits bacterial cell wall synthesis.
   Side effects: Allergic reactions, diarrhea; adjust if penicillin-allergic.

6. Amoxicillin-clavulanate (treatment of wound/ENT infections)
   Class: Aminopenicillin + β-lactamase inhibitor.
   Dose/Time: Weight-based divided doses for 5–10 days if infection occurs.
   Purpose: Treat postoperative or ear/sinus infections as indicated.
   Mechanism: Cell-wall inhibition + β-lactamase blockade.
   Side effects: GI upset, rash, candidiasis.

7. Mupirocin ointment (topical)
   Class: Topical antibiotic.
   Dose/Time: Thin layer 2–3×/day to minor skin infection areas as directed.
   Purpose: Localized skin/wound bacterial control.
   Mechanism: Inhibits bacterial isoleucyl-tRNA synthetase.
   Side effects: Local irritation; avoid deep wounds unless prescribed.

8. Ondansetron
   Class: Antiemetic (5-HT3 antagonist).
   Dose/Time: ~0.15 mg/kg IV/PO peri-operatively or for nausea.
   Purpose: Control vomiting after anesthesia or opioid use.
   Mechanism: Blocks serotonin receptors in gut/brain.
   Side effects: Headache, constipation; rare QT prolongation.

9. Omeprazole (or similar PPI)
   Class: Proton pump inhibitor.
   Dose/Time: Specialist-set pediatric dose, often once daily.
   Purpose: Protect stomach when NSAIDs are needed or treat reflux symptoms.
   Mechanism: Blocks gastric acid secretion (H⁺/K⁺-ATPase).
   Side effects: Abdominal pain, diarrhea; long-term use needs monitoring.

10. Polyethylene glycol (PEG 3350)
    Class: Osmotic laxative.
    Dose/Time: ~0.4–1 g/kg/day adjusted to stool softness.
    Purpose: Prevent constipation from pain meds or reduced activity.
    Mechanism: Draws water into stool.
    Side effects: Bloating, cramps.

11. *Intranasal steroid spray (e.g., fluticasone) **
    Class: Topical corticosteroid (nasal).
    Dose/Time: Use per age-appropriate label and ENT advice.
    Purpose: Reduce nasal mucosal swelling if congestion obstructs airflow.
    Mechanism: Local anti-inflammatory effect.
    Side effects: Local irritation, occasional nosebleeds.
    *Use only if an ENT or pediatrician recommends it.

12. Acetaminophen + ibuprofen rotation
    Class: Analgesic + NSAID strategy.
    Dose/Time: Alternating weight-based doses several hours apart for short periods if approved by the surgeon/pediatrician.
    Purpose: Better pain control while lowering opioid need.
    Mechanism: Dual pathway analgesia.
    Side effects: Same cautions as above; avoid overdosing or overlap.

13. Topical silicone gel (medical device, non-drug)
    Use: Although not a “drug,” surgeons often recommend it for scars.
    Purpose: Improve scar quality.
    Mechanism/Side effects: Hydration barrier; minimal side effects.

14. Short-course oral steroid (specialist-directed)
    Class: Systemic corticosteroid.
    Dose/Time: Short taper only if severe airway edema or significant post-op inflammation per surgeon.
    Purpose: Reduce critical swelling.
    Mechanism: Broad anti-inflammatory effects.
    Side effects: Mood change, hyperglycemia, infection risk; use cautiously.

15. Topical nasal saline (supportive, non-drug)
    Use: Sterile saline sprays/irrigations post-op per ENT guidance.
    Purpose: Moisturize and clear crusts.
    Mechanism: Restores mucosal hydration and flow.
    Side effects: Minimal if used correctly.

Remember: the care team chooses only what is needed. Many children will not need every medicine above.

---

Dietary molecular supplements

Discuss all supplements with your clinicians, especially around surgery.

1. Protein (whey or food-first):
   Dose: Aim ≥1.2–1.5 g/kg/day total protein from diet; supplements if needed.
   Function/Mechanism: Provides amino acids for wound healing and muscle.

2. Vitamin C (ascorbic acid):
   Dose: Age-appropriate RDA up to clinician-approved higher peri-op amounts.
   Function: Collagen synthesis; antioxidant; supports wound healing.

3. Vitamin D3 (cholecalciferol):
   Dose: Per pediatric labs; common maintenance 400–1000 IU/day; higher if deficient as prescribed.
   Function: Bone mineralization, immune modulation.

4. Calcium:
   Dose: Meet age RDAs (generally 700–1300 mg/day from diet/supplement).
   Function: Bone and tooth strength, neuromuscular function.

5. Zinc:
   Dose: Age-appropriate RDA; short peri-op supplement if low intake.
   Function: Enzyme cofactor in skin/wound repair.

6. Iron (only if deficient):
   Dose: Clinician-guided mg/kg elemental iron.
   Function: Corrects anemia to support growth and healing.

7. Omega-3 fatty acids (EPA/DHA):
   Dose: Food-first (oily fish 1–2×/week) or pediatric supplement per label.
   Function: Anti-inflammatory support; may aid pain moderation.

8. B-complex (B12/folate if low):
   Dose: Per labs/dietitian advice.
   Function: Red blood cell and nerve health.

9. Probiotics (during/after antibiotics):
   Dose: Pediatric multi-strain per label while on antibiotics and 1–2 weeks after.
   Function: Supports gut microbiome; may reduce antibiotic-associated diarrhea.

10. Collagen peptides/gelatin (optional):
    Dose: Food-based gelatin broths or labeled supplements.
    Function: Provides glycine/proline—building blocks for collagen; adjunct only.

---

Regenerative / stem-cell” drugs

There are no approved immune-booster or regenerative medicines for AFND. The options below describe research directions or surgical adjuncts; no routine dosing exists for children with AFND.

1. Hedgehog-pathway modulators (experimental): Researchers study how the ZSWIM6 variant disturbs Hedgehog signaling in early development; this is not a current treatment but a biology target.
   Function/Mechanism: Would aim to normalize signaling in models. PMC

2. Patient-derived iPSC models + gene correction (lab only): Cells from patients can be reprogrammed and corrected (e.g., CRISPR) in the lab to study development.
   Function: Disease modeling and drug screening—not clinical therapy.

3. Mesenchymal stem/stromal cells (MSCs) for craniofacial bone (trial settings): Investigated with scaffolds for congenital and traumatic defects; not standard for AFND.
   Function: Potential osteogenesis support in research protocols.

4. Tissue-engineered scaffolds with growth factors (e.g., BMPs) in selected surgeries: Some centers study bone graft substitutes; pediatric safety varies.
   Function: Enhance bone healing in specific defects; surgeon-controlled.

5. 3D-printed patient-specific implants/grafts (surgical tech): Aids reconstruction precision rather than “drug therapy.”
   Function: Improves fit and symmetry; reduces operative time.

6. Gene-therapy conceptual frameworks (education only): Future methods might target ZSWIM6-related pathways, but there are no clinical trials proving benefit yet.
   Function: Scientific roadmap for longer-term solutions.

---

Surgeries

1. Facial bipartition for hypertelorism and midface cleft
   Procedure: Craniofacial surgeons separate and rotate the eye sockets inward, reshape the midface, and reconstruct the nasal bridge; bone grafts may be placed.
   Why: To bring the eyes to normal distance and correct the midline cleft for function and appearance. Wikipedia

2. Structured nasal reconstruction (primary or staged)
   Procedure: Cartilage grafts (often costal) and structured rhinoplasty techniques to rebuild the dorsum and tip; septal support is restored when feasible.
   Why: Improve airflow and nasal shape; address bifid/wide nasal tip. SAGE JournalsMahidol University

3. Repair of median facial clefts/soft-tissue revision
   Procedure: Closure of soft-tissue clefts and later scar revisions; sometimes combined with bone grafting.
   Why: Protect airway, improve oral competence, and cosmetic symmetry. E-ACFS

4. Lower-limb reconstruction (clubfoot and tibial deficiency)
   Procedure: Ponseti casting and tendon procedures for clubfoot; bracing; in selected cases, complex limb reconstruction or rotationplasty per orthopedic protocols.
   Why: Enable plantigrade, braceable foot and functional gait.

5. Polydactyly correction of the foot
   Procedure: Removal or reshaping of extra inner toes with soft-tissue balancing.
   Why: Shoe fit, gait mechanics, and cosmesis.

Note: Surgical plans are individualized and staged over years by a multidisciplinary craniofacial team. rchsd.org

---

Prevention and safety tips

1. Genetic counseling before future pregnancies to discuss ZSWIM6 and testing options. search.clinicalgenome.org

2. Prenatal imaging + genetic testing if a prior child is affected or if ultrasound shows concerning signs. PMC

3. Early referral to a craniofacial center for coordinated care. rchsd.org

4. Infection prevention after surgery: wound care, hand hygiene, follow instructions.

5. Dental and oral-hygiene routines to support jaw and speech health.

6. Helmet and mobility safety during rehab to prevent falls.

7. Sun protection of scars (hats, SPF) to avoid darkening.

8. Nutrition for growth and healing (see diet below).

9. Vaccinations up to date as advised by pediatricians.

10. Mental-health support for child and family during long care journeys.

---

When to see doctors urgently

• Breathing difficulty, noisy breathing that worsens, blue lips, or pauses in breathing.

• Fever, redness, or discharge from surgical sites.

• Severe headache, vomiting, seizures, or sudden behavior change.

• Worsening foot or leg pain, new swelling, or braces causing skin sores.

• Feeding problems with weight loss or dehydration.

• Any concerning change that worries the family—trust your instincts.

---

Foods to focus on—and what to avoid

Eat more:

1. Protein-rich foods (eggs, fish, chicken, lentils) for tissue repair.

2. Dairy or fortified alternatives for calcium.

3. Iron-rich foods (meat, beans) with vitamin-C fruit to aid absorption.

4. Colorful fruits/vegetables for vitamins and antioxidants.

5. Whole grains for steady energy and bowel regularity.

6. Healthy fats (olive oil, nuts, seeds) to support calories and healing.

7. Yogurt/kefir (if tolerated) to support gut health during/after antibiotics.

8. Broths/soups post-op for hydration and easy calories.

9. Soft textures (scrambled eggs, mashed potatoes) if chewing is sore after facial surgery.

10. Plenty of water.

Limit/avoid:

• Sugary drinks and ultra-processed snacks that displace nutrients.

• Very salty/packaged foods that worsen swelling.

• Hard/crunchy foods immediately after facial surgery per surgeon advice.

• Herbal supplements not cleared by your medical team (bleeding risk around surgery).

---

Frequently asked questions

1. Is AFND the same as “frontonasal dysplasia”?
   AFND is a specific, severe subtype with face, brain, and limb findings; it is linked to ZSWIM6 variants. MalaCards

2. What causes AFND?
   A change in the ZSWIM6 gene, usually new (de novo). PMC+1

3. Is it inherited?
   It can be autosomal dominant, but many cases are de novo. A genetics provider can explain recurrence risks. search.clinicalgenome.org

4. Can medicine cure it?
   No medicine reverses AFND. Care is surgical and supportive. rchsd.orgPubMed

5. Will my child need surgery?
   Often yes, staged across childhood, to address facial clefts, nasal structure, eye spacing, clubfoot, or extra toes. Plans are individualized. Wikipedia

6. What about brain differences?
   Some children have brain malformations. Neurology evaluates development and seizures if they occur. jbcgenetics.com

7. What specialists are involved?
   Craniofacial surgeons, orthopedists, neurology, ENT, genetics, PT/OT/SLP, dentistry, psychology, dietetics. Multidisciplinary care is key. rchsd.org

8. Are there clinical trials?
   Trials are uncommon; research focuses on biology and reconstruction methods. Ask your genetics team about registries. search.clinicalgenome.org

9. Will my child walk?
   Many do—with therapy, orthoses, and sometimes surgery—though gait may remain different. Programs are highly individualized.

10. Does AFND affect intelligence?
    Some children have typical learning; others may have developmental challenges. Early therapies and school supports help. jbcgenetics.com

11. How soon after birth does treatment start?
    Evaluation starts early. Some procedures wait until bones grow; others (airway or feeding support) start right away. Wikipedia

12. Are there special risks with anesthesia?
    Airway differences can add complexity. Pediatric anesthesiologists in craniofacial centers are best equipped.

13. What about scarring?
    Modern techniques and scar care (silicone, sun protection) can improve outcomes.

14. Will braces or custom shoes be needed?
    Often yes, to improve alignment and comfort for standing and walking.

15. How can we support our child emotionally?
    Provide honest, age-appropriate information, link with peer groups, and seek counseling when needed.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: September 04, 2025.